Company Summary - Phytopharm PLC (LSE:PYM)
16.50p
0.50p
(-3.03%)
FTSE Fledgling Pharmaceuticals & BiotechnologyMarket cap: £15.600m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Pharmaceutical development and functional food company whose products are generated from medicinal plants
| Financials - Interim (20/5/2009) | ||
|---|---|---|
| Turnover | £m | 0.72 |
| Pre-tax Profit | £m | -2.36 |
| EPS | p | -2.00 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Alistair Taylor | Chairman |
Products Brands & Subsidiaries
Products & Brands
Cogane; Hoodia extract; Myogane; P1; P54; P54v; P55; P57; P58; P59; P61; P63; P64; P7v; PYM60001 series; PYM60004 series; PYM60086...
Subsidiaries
Phytotech Ltd
Broker Sentiment (1 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Blocklisting Interim Review | 12/11/2009 |
| Holding(s) in Company | 04/11/2009 |
| Holding(s) in Company | 23/10/2009 |
For more information
and investor relations, visit the
Phytopharm PLC company website: